A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

This is the same limited use the FDA set in licensing the Novavax COVID-19 vaccine last month. This fall, Moderna anticipates offering both Spikevax and mNexspike as COVID-19 vaccines.

mNexspike becomes Moderna’s third FDA-approved product, joining Spikevax (original COVID-19 vaccine) and mResvia (RSV vaccine). Spikevax is approved/authorized for use by the FDA in individuals ...

A number lambasted Kennedy and the FDA on social media recently when the regulatory agency approved Moderna’s second-generation Covid-19 vaccine, known as mNexspike.

The primary outcome of the study was to demonstrate noninferior vaccine efficacy against COVID-19 starting 14 days after mNexspike compared with that after the comparator vaccine. Findings showed ...